Have A Heart, Save My Liver! Which Countries Restrict Treatment?
A fact sheet, developed by the hepCoalition, provides in-country data about HCV treatment rationing through different forms of restrictions. More
Calendar
Recent materials
Hepatitis C and TB Long-Acting Medicines: Analysis of Patenting Trends and Implications for Access
A patent landscape, released by TAG, investigates potential patent barriers for the development and delivery of long-acting formulations for selected hepatitis C and TB medicines. More
Advocates Urge Cepheid to Reinstate Plans to Commercialize GeneXpert Omni
Advocates call out Cepheid for canceling commercialization of the portable point-of-care GeneXpert Omni testing instrument and urge the company to reinstate plans to launch Omni. More
TAGline: Delivering on the Promise of Long-Acting Formulations
October 2021 issue of TAGline delves deep into the development of long-acting formulations for the treatment and prevention of HIV, TB, hepatitis C, and malaria. More
Have a Heart, Save My Liver! Who Has Access to the Cure in Africa?
TAG’s HCV Community Engagement Officer presented new data on the registration of the hepatitis C cure at the Conference on Liver Disease in Africa (COLDA) 2021. More
Advocates Demand Continuous Catalytic Investment Towards Viral Hepatitis Elimination
An open letter sent to Unitaid demands continuous investment towards HBV and HCV elimination, and to address the needs of 354 million people living with viral hepatitis worldwide. More
